Download Infectious Diseases Pharmacists The Society of

The Society of
Infectious Diseases Pharmacists
The Society was formed in 1990 with a vision
to support the growing numbers of pharmacists
dedicated to practicing, teaching and performing
research in the area of infectious diseases. Since
its inception, The Society has supported the
appropriate use of antimicrobials through
education, research and publication. The Society
achieves this through collaboration with other
professional healthcare associations, such as the
American College of Clinical Pharmacy (ACCP),
the Infectious Diseases Society of America
(IDSA), the American Society of Health-System
Pharmacists (ASHP) and the American Society
for Microbiology (ASM) by co-sponsoring
educational programs at major medical
meetings that promote the appropriate use of
antimicrobials and controlling the spread of
antimicrobial resistance.
The Society members are integral parts of
major national and international regulatory and
decision making committees on antimicrobials
including:
• Anti-Infective and Anti-Viral Drug
Advisory Committee of the FDA
• Therapeutic Working Committees on
Antimicrobial Resistance with the CDC
• Panel members for committees on the
treatment of HIV infection for the
Department of Health and Human Services
• National and International Consensus
Conferences on Antimicrobial Resistance
SIDP is
dedicated to the
advancement of
infectious diseases
pharmacotherapy through
enhanced clinical practice,
research and training.
The Society of
Infectious Diseases
Pharmacists
For more information about SIDP,
visit www.sidp.org or
contact us at the number below.
The Society of Infectious Diseases Pharmacists
823 Congress Avenue, Suite 230
Austin, Texas 78701
(p) 512-479-0425
(f) 512-495-9031
www.sidp.org
[email protected]
Professional Development
Practice & Research
Education
Professional Representation
The Society of Infectious Diseases Pharmacists
Professional Development
The Society of Infectious Diseases Pharmacists (SIDP)
is a nonprofit, professional organization comprised
of pharmacists and other healthcare professionals
involved in patient care, research, teaching, drug
development, and federal regulation dedicated to
promoting the appropriate use of antimicrobials.
SIDP provides education, leadership and advocacy
in all aspects of the treatment of infectious diseases,
and is committed to excellence in infectious
diseases pharmacotherapy.
The mission of The Society is to:
• Advance the subspecialty of infectious diseases
pharmacotherapy in clinical pharmacy.
• Promote, by way of scientific and professional
communication, the contributions and role of
pharmacists in the management of infectious diseases.
• Develop interdisciplinary relationships between The
Society and other professional and regulatory
organizations involved in the development of policies
related to the prevention and management of infectious
diseases.
• Encourage, develop and maintain standards of practice
for individuals with expertise in the pharmacotherapy
and management of infectious diseases.
• Support and promote research addressing the
epidemiology, treatment and prevention of infectious
diseases; the appropriate use of antimicrobials; and the
prevention of management of drug resistance.
The main benefits of membership include:
•
•
•
•
Professional Development
Practice & Research
Education
Professional Representation
Education
• Promotion of the formal recognition of
infectious diseases as a distinct, recognized
area of expertise within the pharmacy
profession
• Newsletter highlighting current infectious
diseases clinical and scientific topics
• State-of-the-art lectures from leading experts
• Educational symposia at major infectious
diseases, infection control, and critical
care meetings
• Opportunities for committee participation
• Collaboration on several consensus papers including topics such as
aerosolized antibiotics, management of seasonal and pandemic
influenza, infectious diseases training for pharmacists, and reflections
on the IDSA/SHEA antimicrobial stewardship guidelines
• Website links to continuing education programs, national infectious
diseases treatment guidelines, drug interaction tools, traineeship
opportunities
• Job posting section of website
Professional Representation
• Networking opportunities at SIDP annual meetings with leaders in
the area of infectious diseases pharmacotherapy and research
Practice & Research
• Sponsorship of infectious diseases residency
programs promoting enhancement of the
specialty
• Research grants and awards supporting
efforts related to clinical practice or basic
research in infectious diseases
pharmacotherapy
• Research on antimicrobial pharmacokinetics, pharmacodynamics,
mechanisms of drug action, mechanisms of antimicrobial resistance,
CMV disease in transplant recipients, and appropriate use of
antibiotics
• Forum for exchange of scientific or clinical information
• Networking opportunities to foster collaboration among members
for common research interests
•
•
•
•
•
Appointment to respected professional and
regulatory committees addressing infectious
diseases related issues:
• FDA Drug Advisory Committee
• CDC Drug-Resistant Streptococcus
pneumoniae Therapeutic Working Group
FDA Antiviral Advisory Committee
Scientific Review Group of the NIAID
CSLI Subcommittee on Medication Use
Standards and Practice Guidelines Committee for IDSA
Infectious Diseases Information Expert Committee of USP
Participation in national guideline development:
• IDSA/SHEA Guidelines for Developing an Institutional Program to
Enhance Antimicrobial Stewardship
• ASHP consensus paper on Vancomycin Serum Concentration
Monitoring
• DHHS Panel for Guidelines on the Use of Antiretroviral Agents in
HIV-1 Infected Adults and Adolescents
• CDC/NIH/HIVMA/IDSA HIV Opportunistic Infection Prevention
and Treatment Guidelines
Participation on medical journal editorial boards:
• Pharmacotherapy
• Antimicrobial Agents and Chemotherapy
• Clinical Infectious Diseases
• Pediatric Infectious Diseases Journal
• Annals of Pharmacotherapy